Amgen (AMGN) Misses Q4 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Amgen (AMGN) PT Raised to $205 at Bernstein Following 4Q
February 2, 2018 8:06 AM ESTBernstein raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $189.00) while maintaining a Market Perform rating following the company's 4Q earnings report. Amgen missed a bit on top line with a bit more of a material miss on EPS ($5,602, -0.7%; $2.89, -14c). The... More
Amgen (AMGN) PT Lowered to $196 at Morgan Stanley
February 2, 2018 6:56 AM ESTMorgan Stanley lowered its price target on Amgen (NASDAQ: AMGN) to $196.00 (from $204.00) while maintaining a Overweight rating.
... MoreAmgen (AMGN) PT Raised to $224 at Oppenheimer
February 2, 2018 6:54 AM ESTOppenheimer raised its price target on Amgen (NASDAQ: AMGN) to $224.00 (from $205.00) while maintaining an Outperform rating.
Analyst Leah Rush Cann commented, "Amgen reported GAAP earnings per share, before a one-time tax-reform charge, of $2.70, which is 9.2% lower than our estimate of $2.97. Earnings were... More



